Ignite Creation Date:
2024-05-06 @ 9:09 AM
Last Modification Date:
2024-10-26 @ 12:10 PM
Study NCT ID:
NCT02910882
Status:
TERMINATED
Last Update Posted:
2019-04-11
First Post:
2016-08-12
Brief Title:
PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized Unresectable Pancreatic Cancer
Sponsor:
Scripps Health
Organization:
Scripps Health
Organization Data
Organization:
Scripps Health
Class:
OTHER
Study ID:
PEGPH20-GEM-XRT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Scripps Health
Lead Sponsor Class:
OTHER
Responsible Party:
Darren Sigal MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Scripps Health
Old Name:
None
Old Organization:
None